Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
Portfolio Pulse from
Milestone Scientific Inc. reported a 22% increase in revenue for Q3 2024, driven by a 57% rise in international dental sales. The company is expanding the rollout of its CompuFlo® Epidural System in the U.S. following Medicare price assignment.
November 14, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Milestone Scientific Inc. achieved a 22% revenue increase in Q3 2024, with significant growth in international dental sales and expansion of its CompuFlo® Epidural System in the U.S.
The 22% revenue increase and 57% rise in international dental sales indicate strong business performance. The expansion of the CompuFlo® Epidural System, supported by Medicare price assignment, suggests potential for further growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100